As an anabolic (protein building) and anticatabolic (protein sparing)
agent, SerostimTM therapy results in a significant increase of lean body
mass and weight, with a decrease in body fat. During the course of earlier
Phase III trials it was learned that preventing the continued loss, as well
as promoting the accrual, of lean body mass, are the keys to improving
physical function. The two placebo-controlled trials of SerostimTM in
people with AIDS wasting up to 12 weeks in length found no difference in
survival between groups.
SerostimTM [somatropin (rDNA origin) for injection] is indicated for the
treatment of AIDS wasting or cachexia. This indication is based on
analyses of surrogate endpoints (lean body mass and weight) in studies of
up to 12 weeks in duration. Concomitant antiviral therapy is necessary.
The continued use of SerostimTM treatment should be reevaluated in patients
who continue to lose weight in the first two weeks of treatment. For more
medical information please call PRIORITY PHARMACY at
1-800-487-7113 and
speak to Dr. Richard Simons, our clinical pharmacist.
PRIORITY PHARMACY, a national pharmaceutical prescription service offering
next-day home-delivery for HIV/AIDS patients, is proud to announce that as
a specialty provider for SerostimTM, prescriptions will be accepted
immediately. For additional information and a copy of "Physicians Letter
of Medical Necessity" please contact
1-800-487-7113.
SerostimTM is approved for Medi-Cal in California and is in Stock now.